Palvella Therapeutics (PVLA) EBITDA Margin (QoQ) (2014 - 2023)
Palvella Therapeutics (PVLA) EBITDA Margin (QoQ) (2014 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Palvella Therapeutics |
1.49 Bn |
1.23 Bn |
- |
| Date | Value |
|---|
| Sep 30, 2023 |
-9,162.00 |
| Jun 30, 2023 |
71,109.00 |
| Sep 30, 2022 |
-350,524.00 |
| Jun 30, 2022 |
-26,226.00 |
| Mar 31, 2022 |
14,240.00 |
| Dec 31, 2021 |
39,276.00 |
| Sep 30, 2021 |
2,813.00 |
| Jun 30, 2021 |
-58,025.00 |
| Mar 31, 2021 |
71,291.00 |
| Dec 31, 2020 |
-26,485.00 |
| Sep 30, 2020 |
-43,382.00 |
| Jun 30, 2020 |
-2,123.00 |
| Mar 31, 2020 |
4,637.00 |
| Dec 31, 2019 |
-6,386.00 |
| Sep 30, 2019 |
22,888.00 |
| Jun 30, 2019 |
-12,246.00 |
| Mar 31, 2019 |
182,490.00 |
| Dec 31, 2018 |
-185,569.00 |
| Sep 30, 2018 |
-10,681.00 |
| Jun 30, 2018 |
26,799.00 |
